Best Cortellis Alternatives for Biopharma Teams in 2026
Maven Bio provides live intelligence for biopharma decision-making. It monitors developments against team priorities and applies source-linked edits to selected working files, with revision history, rollback, and maintained Word, Excel, and PowerPoint deliverables1.
Cortellis alternatives cover different parts of a development assessment. For example, Citeline emphasizes curated pipeline and trial planning, Evaluate connects pipelines with commercial forecasts, and Maven Bio connects evidence-led comparisons to maintained team materials23. This shortlist covers ten products, from structured drug-pipeline and clinical-trial research to commercial intelligence platforms with pipeline coverage.

Pipeline and trial research capabilities
| Product | Automatic source-linked updates to existing files | Trial design and endpoint detail | Linked deal and financing records | Editable Word, Excel, and PowerPoint | MCP and API | Consensus sales forecasts |
|---|---|---|---|---|---|---|
| Cortellis | Not described | Yes | Deals; financing not described | Word and Excel exports | Yes | Yes |
| Maven Bio | Yes | Yes | Yes | Yes | Yes | No |
| Citeline | Not described | Yes | Not described | Data exports | API; MCP not described | Not described |
| Evaluate | Not described | Not described | Yes | Not described | API; MCP not described | Yes |
| GlobalData | Not described | Yes | Yes | Not described | Yes | Yes |
| DealForma | Not described | Not described | Yes | Data/chart exports | API; MCP not described | Not described |
| BioCentury BCIQ | Not described | Not described | Yes | Excel exports | Not described | Not described |
| Patsnap Synapse | Not described | Yes | Yes | Word reports | Yes | Not described |
| Sleuth | Not described | Yes | Deals; financing not described | Not described | Yes | Not described |
| Gosset | Not described | Yes | Deals; financing not described | Editability not described | Yes | Not described |
| AlphaSense | On request | Not described | Yes | ✓, beta | ✓, MCP beta | Not described |
'Not described' means the company's public pages do not describe the capability.
Where Cortellis fits
Cortellis documents trial-design and endpoint detail, plus Word and Excel exports45. Its CCI MCP server provides drug and company pipelines, deals, and consensus sales forecasts, alongside linked company API records67.
Maven Bio
Best for
Turning pipeline evidence into maintained assessment files.
Linked drugs, trials, companies, deals, and financing give teams a biopharma research foundation with source documents attached8. Smart Tables investigate each candidate against team-defined criteria, retaining supporting quotes, evidence ratings, and open questions, while Research Agent produces editable reports, workbooks, and presentations in team templates910.
Pros
Connected evidence and consistent comparisons, with MCP, API, and connectors for supported assistants and systems81.
Cons
No built-in broker research.
Citeline
Best for
Curated pipeline screening connected to clinical planning.
Pharmaprojects+ combines drug-development profiles, Company Compare, Drug Similarity, and Ella's conversational pipeline searches2. Trialtrove+ adds trial designs, endpoints, eligibility, enrollment metrics, and study timelines, with links to drug and site intelligence for protocol and feasibility research11.
Pros
Connected drug, trial, and investigator datasets, available through REST APIs and scheduled exports12.
Evaluate
Best for
Assessing a pipeline alongside commercial expectations.
Evaluate Pharma brings product pipelines, consensus forecasts, historical sales, and development events into commercial assessment3. Ask Ella answers questions about company pipelines and market opportunities, with results traced to underlying Evaluate records so teams can examine the data behind the answer13.
Pros
Forecasts and pipeline intelligence support market sizing, portfolio assessment, and commercial comparisons314.
Cons
Ask Ella draws from Evaluate datasets and does not search the web13.
GlobalData
Best for
Combining development research with disease-market intelligence.
GlobalData promotes drug and trial databases alongside epidemiology, commercial forecasts, and regulatory milestones1516. Ava supports research templates and uploaded context, while separate API and MCP offerings deliver data into company systems and compatible research assistants1718.
Pros
Drug, trial, and therapeutic-market research sit within the same pharmaceutical intelligence offering15.
Cons
Unresolved MCP query filters can be dropped, changing the scope of the returned research19.
DealForma
Best for
Connecting development assets to transaction comparables.
DealForma describes company and pipeline profiles alongside clinical trials, regulatory information, licensing transactions, and financing histories20. Its Tableau dashboards support filtered transaction analysis and downloads of charts or underlying data for presentations and further work on a team's own comparisons21.
Pros
Transaction fields connect financial terms with development stage, modality, indication, target, and territory20.
Cons
Direct research assistance is available during Pacific weekday business hours20.
BioCentury BCIQ
Best for
Pipeline research with company and financing context.
BCIQ connects products, companies, deals, and financial data in an interactive database with disease and target landscapes22. Teams can save filter sets, build company groups, inspect linked profiles, and export table data to Excel for their own assessments and reporting23.
Pros
Integrated modules support comparisons across development programs, company activity, and capital formation22.
Cons
Chart visuals are not directly exportable, although their underlying data can be downloaded24.
Patsnap Synapse
Best for
Researching development programs alongside patent evidence.
Synapse connects drug, target, clinical-trial, patent, and scientific-literature information for development research2526. Hiro summarizes selected material and generates downloadable Word analysis reports, while drug exports let teams choose fields and connect target or indication identifiers to other datasets2728.
Pros
Clinical and patent context support scientific comparisons before information is exported for further analysis29.
Cons
Drug-search results saved to a workspace do not automatically update30.
Sleuth
Best for
Connected biopharma datasets with optional research support.
Sleuth promotes linked drug, trial, company, and deal data, including translated Chinese-language publications and source documents31. Studio supports iterative analyses and custom datasets, while MCP and API access bring its research foundation into external assistants or a team's own applications32.
Pros
Source-linked datasets combine clinical development, corporate context, and translated Chinese-source material31.
Cons
The optional Concierge service handles one active managed research project per slot33.
Gosset
Best for
Asset research with trial progression forecasts.
Gosset supports connected research across assets, trials, companies, and deals through its assistant integrations3435. Its platform describes cited reports delivered as documents, spreadsheets, slide decks, or interactive reports, alongside trial-outcome comparisons and configurable pharmaceutical research dashboards with primary-source links36.
Pros
Native prediction commands estimate trial progression and primary-completion timing alongside development research37.
Cons
Early-stage progression estimates require an external late-phase probability to represent full approval odds37.
AlphaSense
Best for
Combining clinical research with premium market content.
AlphaSense's Clinical Trial & Drug Data links drug, indication, company, target, and mechanism profiles with clinical and regulatory information38. SuperAnalyst researches those records alongside premium content and produces source-linked documents, presentations, and spreadsheets, including decks based on uploaded team templates3940.